SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ZIM Laboratories invests Rs 89.45 lakh in ZIMTAS

09 Apr 2026 Evaluate

ZIM Laboratories has invested Rs 89.45 lakh which is AUD 1,35,000 (Australian Dollars) in the equity shares of ZIMTAS. This investment was made out of a total approved amount of Rs 2 crore. Post investment, the company holds 99.96% of the total share capital of ZIMTAS.

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.


Zim Laboratories Share Price

108.60 5.15 (4.98%)
09-Jun-2026 15:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1778.80
Dr. Reddys Lab 1270.30
Cipla 1376.05
Zydus Lifesciences 1105.45
Lupin 2264.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×